Neuroimaging of Parkinson's
Washington University School of Medicine · with National Institute of Neurological Disorders and Stroke (NINDS), Michael J. Fox Foundation for Parkinson's Research · NCT07024875
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- August 1, 2025
- Record last updated
- April 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Parkinson's Disease (PD) is a neurodegenerative disorder caused by dysfunction in both subcortical structures and the cortex. The investigators recently discovered a new brain system called the Somato-Cognitive Action Network (SCAN), which could be a primary locus of dysfunction in PD. Here, the investigators will use magnetic resonance imaging techniques in PD patients to test whether SCAN is critical for PD. The investigators will determine whether SCAN is connected to PD-relevant subcortical structures, and whether PD patients exhibit altered subcortical-to-SCAN connectivity. If successful, this work will identify SCAN as a specific circuit altered in PD patients that can serve as a new target for future neuromodulatory PD therapies.
Conditions: Parkinsons Disease (PD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Must meet specific health and cognitive criteria depending on the group. For PD participants
- Clinical diagnosis of Parkinson's Disease
- Must not meet dementia criteria For Healthy Control Participants
- Normal or benign neurological exam
- Normal cognition
- No first-degree relatives with Parkinson's Disease
Exclusion Criteria
- Neurological Disorders (other than PD)
- Any other neurological condition
- Significant Head Injury
- Head injury with loss of consciousness >5 minutes
- Or any neurological sequelae
- Psychiatric Disorders
- Schizophrenia
- Bipolar Disorder
- Epilepsy
- Serious Medical Conditions
- End-stage organ failure
- Ongoing cancer treatment
- Cognitive Impairment
- Diagnosis of dementia
- MMSE score \<24 or MoCA score \<21
- MRI contraindications
- Metal implants
- claustrophobia
- Weight over 300 lbs (due to weight restrictions of the MRI scanner)
Recruiting US locations
East Imaging Building
St Louis, MO 63110
Study contacts (from the official record)
- Danny Bower · 314-273-4429 · bower@wustl.edu
Similar studies in Missouri
All neurology studies in Missouri →- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
University of Pennsylvania
- Location
- St Louis, MO + 2 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- St Louis, MO + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Chesterfield, MO + 24 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- St Louis, MO + 21 other US sites
- Eligibility basics
- Ages 18–75